No. | Antibodies | EIA OD (450 nm) Value |
---|
gD26-18 | Ab to MEAP | 1.125 ± 0.041 |
gB2466-473 | Ab to MEAP | 0.977 ± 0.039 |
gC2216-223 | Ab to MEAP | 0.899 ± 0.031 |
gE2483-491 | Ab to MEAP | 1.102 ± 0.040 |
gG2572-579 | Ab to MEAP | 0.182 ± 0.011 |
gI2286-295 | Ab to MEAP | 0.792 ± 0.029 |
MEAP | Ab to gD2 | 1.099 ± 0.037 |
MEAP | Ab to gB2 | 0.986 ± 0.031 |
MEAP | Ab to gC2 | 0.893 ± 0.029 |
MEAP | Ab to gE2 | 1.013 ± 0.041 |
MEAP | Ab to gG2 | 0.201 ± 0.011 |
MEAP | Ab to gI2 | 0.876 ± 0.031 |
Control 1 | Ab to MEAP | 0.116 ± 0.011 |
Control 2 | Ab to gD2 | 0.121 ± 0.010 |
- The selected synthesized B cell epitopes were coated as antigens. The antibodies to the MEAP reacted with the epitopes. The antigenicities were detected by EIA. The MEAP was coated as an antigen. The antibodies to the B, C, D, E, G and I glycoproteins (ABcam) reacted with the MEAP, and the results can be seen in the Table. No. represents the number of the peptides and the MEAP. Control 1 is a peptide other from the HSV-2 glycoproteins. Control 2 is a antibody other than antibodies to the B, C, D, E, G and I glycoproteins of HSV-2. The O.D. mean values (at 450 nm) are shown in the Table.